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httpicense.Abstract We present a rare case of esophageal tuberculosis causing odynophagia. Tuberculosis of
the esophagus is a rare condition, even in countries with a high incidence of tuberculosis (TB) and
studies estimate that it constitutes about 0.3% of gastrointestinal TB cases. The case emphasizes the
diverse ways tuberculosis can present.
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Tuberculosis. Open access under CC BY-NC-ND license.Our patient was a 24 year old male who presented with
1 year history of upper abdominal discomfort, odynophagia,
and post prandial distention. For two months he was also hav-
ing dry cough, dyspnea on exertion, progressive distention of
abdomen and low grade evening rise of temperature. On exam-
ination he was found to have grade 1 clubbing, ascites and
small axillary lymph nodes.
Hemogram and serum chemistry were normal. HIV serol-
ogy was also negative.ail.com (K.H. Changal),
), reyazpara2286@gmail.com
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://dx.doi.org/10.1016/j.ejcdt.2013.0Chest X ray showed a right hilar lymph node (Fig. 1). USG
abdomen conﬁrmed moderate ascites and showed multiple
internal septations.
A diagnostic paracentesis showed a lymphocytic exudative
ascites with high protein, high lactate dehydrogenase, high
adenosine deaminase, and a serum ascites albumin gradient
of 0.3. No acid fast bacilli could be demonstrated in the ascitic
ﬂuid microscopically but polymerase chain reaction for Myco-
bacterium tuberculosis was positive. There were no malignant
cells. Mantoux skin test was negative.
Esophageogastroduodenoscopy showed longitudinal
esophageal friable ulcers at 32 cms from incisors (Fig. 2).
Biopsy was done which showed chronic granulomatous inﬂam-
mation (Fig. 3). PCR was positive for M. tuberculosis in the
esophageal biopsy.
Contrast enhanced computed tomography (CECT) chest
showed mediastinal lymphadenopathy with normal lung
parenchyma (Fig. 4). CECT abdomen showed peritoneal
thickening and ascites with septations.
With these investigations a diagnosis of secondary esopha-
geal tuberculosis with extension from nearby mediastinalhe Egyptian Society of Chest Diseases and Tuberculosis.
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Fig. 2 Arrow showing the longitudinal esophageal ulcers.
Fig. 3 Esophageal biopsy showing chronic granulomatous
inﬂammation with the top arrow showing a granuloma; and the
bottom arrow showing a giant cell.
Fig. 4 CECT showing mediastinal lymphadenopathy.
Fig. 1 A chest X-ray showing a right hilar node (arrow).
350 K.H. Changal et al.nodes; with tubercular ascites was made. The patient was
started on anti tubercular drugs for a total duration of
6 months. At follow up on 2 months the odynophagia and
ascites had disappeared; the patient was afebrile and asymp-
tomatic. After 6 months of treatment repeat esophagoscopy
was normal with no complications.
Discussion
The global burden of tuberculosis remains enormous, mainly
because of poor control and coexisting nature ofM. tuberculo-
sis and HIV. Tuberculosis has been known to involve the
esophagus, either as a primary infection or as a secondary man-
ifestation of reactivated disease. The exposure of the esophagus
to the organism is limited by the rapid clearance of infected spu-
tum by means of coordinated peristalsis, combined with up-
right posture and an intact lower esophageal sphincter [1].
Esophageal tuberculosis is almost always associated with medi-astinal lymphadenopathy with or without a tracheo-esophageal
ﬁstula [2]. The twomost common differential diagnoses are car-
cinoma of the esophagus and Crohn’s disease of the esopha-
gus [3,4]. Tuberculosis of the esophagus is a rare condition,
even in countries with a high incidence of tuberculosis
(TB) [5,6], and studies estimate that it constitutes about 0.3%
of gastrointestinal TB cases [7]. Involvement of the gastrointes-
tinal tract occurs through ingestion of infected sputum or
hematogenous spread from primary pulmonary TB [8]. Most
cases of esophageal tuberculosis are secondary to direct exten-
sion from adjacent structures, such as mediastinal lymph nodes
or pulmonary sites. Primary esophageal tuberculosis is even
rarer [9]. Esophagic involvement by tuberculosis usually affects
the middle third of the esophagus at the carina level [10].
The most frequent symptom reported in esophageal tuber-
culosis is dysphagia, which occurs in about 90% of cases [11].
Other symptoms are odynophagia and retrosternal pain and
the occurrence of symptoms such as fever, weight loss and an-
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indicative of an underlying ﬁstula between the esophagus
and respiratory tract. In our patient the predominant symptom
was odynophagia. Infection with human immunodeﬁciency
virus, immunosuppressive therapy, and immigration from
tuberculosis-endemic areas are risk factors for esopha-
geal tuberculosis [2]. Complications include bleeding, perfora-
tion, ﬁstula formation [12], aspiration pneumonia, fatal
hematemesis, traction diverticula, and esophageal strictures
[13] which were not present in our patient.
Approximately 65% of patients with esophageal tuberculo-
sis have nonspeciﬁc ﬁndings on chest radiograph suggestive
of tuberculosis. Enlarged lymph nodes with a hypodense cen-
ter on computed tomography scan of the chest that are charac-
teristic of tuberculous lymphadenitis are observed in the
majority of these patients [13] as was seen in our patient.
Diagnosis of esophageal tuberculosis can be made by
esophagoscopy or biopsy of associated mediastinal lymphade-
nopathy [11]. A differential diagnosis of esophageal tuberculo-
sis includes esophageal carcinoma, Crohn’s disease, moniliasis,
actinomycosis, syphilis, and esophageal injury secondary to
ingestion of caustic material [13].
Esophageal TB is managed with anti-tuberculous drugs;
surgery being reserved for complications including a non-heal-
ing tracheooesophageal or bronchooesophageal ﬁstula, stric-
ture, or bleeding from an aortooesophageal ﬁstula [2,6,11]. A
6-to-9–month course of anti-tuberculous chemotherapy is suf-
ﬁcient for immunocompetent patients treated with a regimen
consisting of four ﬁrst-line drugs, namely isoniazid, rifampicin,
ethambutol, and pyrazinamide for the initial 2 months, then
continuing with isoniazid and rifampicin for another
4–7 months [2,6,14]. Our patient responded to a 6 month treat-
ment only. It is necessary to give therapy for longer if one or
more of these drugs cannot be used because of intolerance or
drug resistance [14]. In cases ofMDR-TB, deﬁned as TB caused
by organisms showing in vitro resistance to at least both isoni-
azid and rifampicin, the total treatment duration should be ex-
tended to at least 18 months, and the regimen should comprise
5 to 6 drugs to which the organisms are susceptible for the ini-
tial 6 months, followed by 3 to 4 drugs subsequently [15].
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